Ovo Labs has developed three therapeutic treatments that reduce genetic errors in eggs, “dramatically” boosting the chances of conception.

TNW is a technology media company that covers the latest trends, news, and insights in the tech industry. With a focus on innovation, entrepreneurship, and digital culture, TNW offers resources for developers, startups, and tech enthusiasts. Developers can learn about emerging technologies, industry trends, and best practices through TNW's articles, podcasts, and events.

The Next Web

German biotech startup Ovo Labs has developed three therapeutic treatments aimed at reducing genetic errors in human eggs, potentially boosting IVF success rates. The company, founded by leading fertility experts, has shown success in improving egg quality in old mice and isolated human eggs. It recently secured €4.6 million in funding to further its research and aims to integrate its technology into standard IVF practices pending regulatory approval.

Fertility startup ‘rejuvenates’ human eggs to boost chances of conception